SCHEMBL6978636

SCHEMBL6978636

CCOC(=O)CN(c1ccc2c(c1)CCCN2C(=O)CCc1ccc(C(=O)OCC)cc1C(=N)N)S(=O)(=O)c1cccc2ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 1/20 0.36
PDK2 Q15119 1/20 0.36
PDK3 Q15120 1/20 0.36
PDK4 Q16654 1/20 0.36
ALDH1A1 P00352 4/20 0.36
LMNA P02545 3/20 0.36
NPSR1 Q6W5P4 3/20 0.36
HPGD P15428 1/20 0.36
THRB P10828 1/20 0.36
RORC P51449 1/20 0.35
PARP1 P09874 1/20 0.35
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
KMT2A Q03164 1/20 0.34
MAPT P10636 3/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TP53 P04637 1/20 0.33
POLB P06746 2/20 0.33
NOTUM Q6P988 1/20 0.33
TSHR P16473 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7089640 0.95 PDK1 (0.36) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL6982379 0.90 THRB (0.35) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL6984481 0.88 F2 (0.41) PDK1PDK2PDK3PDK4ALDH1A1
Hydrochloric Acid SCHEMBL6979622 0.88 F2 (0.39) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL6979175 0.87 USP2 (0.39) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL6984189 0.86 F2 (0.39) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL7085095 0.86 ALDH1A1 (0.36) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL6984846 0.85 USP2 (0.38) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL6979712 0.85 F2 (0.35) ALDH1A1HPGDTHRBRORCPARP1
SCHEMBL7088164 0.84 THRB (0.36) PDK1PDK2PDK3PDK4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed